Construction and characterization of feline immunodeficiency virus proviral mutants that coexpress interferon gamma and green fluorescent protein

AIDS Research and Human Retroviruses

Volumn 22, Issue 4, 2006, Pages 342-349

  Gupta, Soumi ^a,c   Leutenegger, Christian ^a   Dean, Gregg ^b   Sparger, Ellen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c MONOGRAM BIOSCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; ENHANCED GREEN FLUORESCENT PROTEIN; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; IMMUNOMODULATING AGENT; VIF PROTEIN;

ARTICLE; EXPRESSION VECTOR; FELINE IMMUNODEFICIENCY VIRUS; FLUORESCENCE MICROSCOPY; GENE; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENE MUTATION; IMMUNOCYTOCHEMISTRY; IMMUNOMODULATION; LENTIVIRINAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROVIRUS; REPORTER GENE; SEQUENCE HOMOLOGY; START CODON; VACCINATION; VIRUS MUTANT; VIRUS REPLICATION;

ANIMALS; CATS; CELL LINE; GENE DELETION; GENES, VIRAL; GREEN FLUORESCENT PROTEINS; IMMUNODEFICIENCY VIRUS, FELINE; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; MICROSCOPY, FLUORESCENCE; PROVIRUSES; T-LYMPHOCYTES;

EID: 33646139383     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.342     Document Type: Article

References (39)

1. Lockridge K, Chien M, Luciw PA, and Sparger EE: Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA. Virology 2000;273:67-79.
2. Talbott RL, Sparger EE, Lovelace KM, et al.: Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc Natl Acad Sci USA 1989;86:5743-5747.
3. Pedersen NC, Ho EW, Brown ML, and Yamamoto JK: Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 1987;235:790-793.
4. Olmsted RA, Hirsch VM, Purcell RH, and Johnson PR: Nucleotide sequence analysis of feline immunodeficiency virus: Genome organization and relationship to other lentiviruses. Proc Natl Acad Sci USA 1989;86:8088-8092.
5. Bendinelli M, Pistello M, Lombari S, et al.: Feline immunodeficiency virus: An interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev 1995;8:87-112.
6. Elder JH, Dean GA, Hoover EA, et al.: Lessons from the cat: Feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1998;14:797-801.
7. Lockridge K, Himathongkham S, Sawai ET, Chien M, and Sparger EE: The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages. Virology 1999;261:25-30.
8. Leitner WW, Ying H, and Restifo NP: DNA and RNA-based vaccines: Principles, progress and prospects. Vaccine 1999;18:765-777.
9. Hughes HPA: Cytokine adjuvants: Lessons from the past-guidelines for the future? Vet Immunol Immunopathol 1998;63:131-138.
10. Hughes HPA and Babiuk LA: Potentiation of the immune response by cytokines. In: Cytokines in Animal Health and Disease (Myers M and Murtaugh M, eds.). Marcel Dekker, New York, 1995, pp. 183-202.
11. Pasquini S, Xiang Z, Wang Y, et al.: Cytokines and costimulatory molecules as genetic adjuvants. Immunol Cell Biol 1997;75: 397-401.
12. Biron CA and Sen GC: Interferons and other cytokines. In: Fields Virology, Vol. 1 (Knipe DM and Howley PM, eds.). Lippincott Williams & Wilkins, Philadelphia PA, 2001, pp. 321-351.
13. Dunham ST, Flynn JN, Rigby MA, et al.: Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18. Vaccine 2002;20: 1483-1496.
14. Barouch DH, Santra S, Schmitz JE, et al.: Control of viremia and prevention of clinical AIDS in rhesus macaques by cytokine-augmented DNA vaccination. Science 2000;290:486-491.
15. Barouch DH, Santra S, Steenbeke TD, et al.: Augmentation and suppression of immune responses to HIV-DNA vaccine by plasmid cytokine/IG administration. J Immunol 1998;161:1875-1882.
16. Flynn JN, Hosie MJ, Rigby MA, et al.: Factors influencing cellular immune responses to feline immunodefiency virus induced by DNA vaccination. Vaccine 2000;18:1118-1132.
17. Hosie MJ, Flynn JN, Rigby MA, et al.: DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies. J Virol 1998;72:7310-7319.
18. Leutenegger CM, Boretti FS, Mislin CN, et al.: Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif. J Virol 2000;74:10447-10457.
19. Giavedoni L, Ahmad S, Jones L, and Yilma T: Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques. J Virol 1997;71:866-872.
20. Stahl-Hennig C, Gundlach BR, Dittmer U, et al.: Replication, immunogenicity, and protective properties of live-attenuated simian immunodeficiency viruses expressing interleukin-4 and interferon-γ. Virology 2003;305:473-485.
21. Sawai ET, Hamza MS, Ye M, Shaw KES, and Luciw PA: Pathogenic conversion of live, attenuated simian immunodeficiency virus vaccines is associated with expression of truncated nef. J Virol 2000;74:2038-2045.
22. Gundlach BR, Linhart H, Dittmer U, et al.: Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2. J Virol 1997;71:2225-2232.
23. Giavedoni LD and Yilma T: Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon. J Virol 1996;70:2247-2251.
24. Alexander L, Illyinskii PO, Lang SM, et al.: Determinants of increased replicative capacity of serially passaged simian immunodeficiency virus with nef deleted in rhesus monkeys. J Virol 2003;77:6823-6835.
25. Baba TW, Jeong YS, Penninck D, Bronson R, Greene MF, and Ruprecht RM: Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 1995;267:1820-1825.
26. Baba TW, Liska V, Khimani AH, et al.: Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat Med 1999;5:194-203.
27. Gundlach BR, Lewis MG, Sopper S, et al.: Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain. J Virol 2000;74: 3537-3542.
28. Phillips TR, Talbott RL, Lamont C, Muir S, Lovelace K, and Elder JH: Comparison of two host cell range variants of feline immunodeficiency virus. J Virol 1990;64:4605-4613.
29. Jameson P and Essex M: Inhibition of feline leukemia virus replication by human leukocyte interferon. Antiviral Res 1983;3: 115-120.
30. Ho SN, Hunt HD, Horton RM, Pullen JK, and Pease LR: Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989;77:51-59.
31. Bigornia L, Lockridge KM, and Sparger EE: Construction and in vitro characterization of attenuated FIV LTR mutant viruses. J Virol 2001;75:1054-1060.
32. Lerner DL, Grant CK, De Parseval AP, and Elder JH: FIV infection of Il-2-dependent and -independent feline lymphocyte lines: Host cells range distinctions and specific cytokine upregulation. Vet Immunol Immunopathol 1998;65:277-297.
33. Gemeniano MC, Sawai ET, Leutenegger CM, and Sparger EE: Feline immunodeficiency virus Orf-A is required for virus particle formation and virus infectivity. J Virol 2003;77:8819-8830.
34. Dandekar S, Beebe AM, Barlough J, et al.: Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats. J Virol 1992;66:4040-4049.
35. Leutenegger CM, Klein D, Hofmann-Lehmann R, et al.: Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan® fluorogenic real-time detection system. J Virol Methods 1999;78:105-116.
36. LaSalle J and Lalande M: Flow cytometry and FISH to investigate allele-specific replication timing and homologous association of imprinted chromosomes. Methods Mol Biol 2001;181:181-191.
37. Ruprecht RM, Baba TW, Rasmussen R, Hu Y, and Sharma PL: Murine and simian retrovirus models: The threshold hypothesis. AIDS 1996;10:S33-S40.
38. Barouch DH, Santra S, Tenner-Racz K, et al.: Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF. J Immunol 2002;168:562-568.
39. Barouch DH, Craiu A, Kuroda MJ, et al.: Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys. Proc Natl Acad Sci USA 2000;97:4192-4197.